Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function

Journal of Pediatrics

Volumn 135, Issue 6, 1999, Pages 770-772

  Grasemann, Hartmut ^a,b,c   Gaston, Benjamin ^a,b,c   Fang, Kezhong ^a,b,c   Paul, Karl ^a,b,c   Ratjen, Felix ^a,b,c,d  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c HUMBOLDT UNIVERSITY   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; NITRATE; NITRIC OXIDE; NITROSO DERIVATIVE; NITROSOTHIOL DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BRONCHODILATATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG FUNCTION; LUNG LAVAGE; LUNG VENTILATION PERFUSION RATIO; PRIORITY JOURNAL;

EID: 0033505556     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70101-0     Document Type: Article

References (15)

1. 1. Gaston B, Reilly J, Drazen JM, Fackler J, Ramdev P, Arnelle D, et al. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci USA 1993;90:10957-61.
2. 2. Gaston B, Sears S, Woods J, Hunt J, Ponaman M, McMahon T, et al. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 1998;351:1317-9.
3. 3. Xu L, Eu JP, Meissner G, Stamler JS. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 1998; 279:234-7.
4. 4. Kowaluk EA, Fung HL. Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols. J Pharmacol Exp Ther 1990;176:91-5.
5. 5. Sandau K, Brune B. The dual role of S-nitrosoglutathione (GSNO) during thymocyte apoptosis. Cell Signal 1996; 8:173-7.
6. 6. Clancy RM, Levartovsky D, Leszczynska-Piziak J, Yegudin J, Abramson SB. Nitric oxide reacts with intracellular glutathione and activates the hexose monophosphate shunt in human neutrophils: evidence for S-nitrosoglutathione as a bioactive intermediary. Proc Natl Acad Sci USA 1994;91:3680-4.
7. 7. Stamler JS, Toone EJ, Lipton SA, Sucher NJ. (S)NO signals: translocation, regulation and a consensus motif. Neuron 1997;18:691-6.
8. 8. Kamosinska B, Radomski MW, Duszyk M, Radomski A, Man SF. Nitric oxide activates chloride currents in human lung epithelial cells. Am J Physiol 1997;272:1098-104.
9. 9. Meng QH, Springall DR, Bishop AE, Morgan K, Evans TJ, Habib S, et al. Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol 1998; 184:323-31.
10. 10. Ratjen F, Rietschel E, Ballmann M, Griese M, Kleinau I, Wahn U, et al. Airway inflammation in CF patients with normal lung function [abstract]. Eur Respir J 1997;10:302A.
11. 11. Grasemann H, Michler E, Wallot M, Ratjen F. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis. Pediatr Pulmonol 1997;24:173-7.
12. 12. Grasemann H, Ioannidis I, Tomkiewicz RP, de Groot H, Rubin BK, Ratjen F. Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child 1998;78:49-53.
13. 13. Jensen DE, Belka GK, Du Bois GC. S-nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme. Biochem J 1998;331: 659-68.
14. 14. Jones KL, Bryan TW, Jinkins PA, Simpson KL, Grisham MB, Owens MW, et al. Superoxide released from neutrophils causes a reduction in nitric oxide gas. Am J Physiol 1998;19: L1120-6.
15. 15. Hollocher T. The enzymology and occurrence of nitric oxide in the biological nitrogen cycle. In: Lancaster J, editor. Nitric oxide: principles and actions. San Diego: Academic Press; 1996. p. 289-343.